Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shashank Joshi

Showing results (61-70 of 113) with videos related to

Pageof 12
Sort By:
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|January 27, 2023
Expert Consensus Recommendations on Time in Range for Monitoring Glucose Levels in People with Diabetes: An Indian PerspectiveViswanathan Mohan, Shashank Joshi, Ambrish Mithal, et al.
The Lancet Regional Health. Southeast Asia|November 14, 2022
Correction to "SARS-CoV-2 accelerated clearance using a novel nitric oxide nasal spray (NONS) treatment: A randomized trial"Monika Tandon, Wen Wu, Keith Moore, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|March 25, 2022
Expert Opinion: Optimum Clinical Approach to Combination-Use of SGLT2i + DPP4i in the Indian Diabetes SettingManoj Chadha, Ashok Kumar Das, Prasun Deb, et al.
Clinical Diabetes and Endocrinology|November 15, 2021
Type 2 diabetes reversal with digital twin technology-enabled precision nutrition and staging of reversal: a retrospective cohort studyParamesh Shamanna, Shashank Joshi, Lisa Shah, et al.
Clinical Pharmacokinetics|October 5, 2019
An Open-Label, Single-Period, Two-Stage, Single Oral Dose Pharmacokinetic Study of Remogliflozin Etabonate Tablet 100 and 250 mg in Healthy Asian Indian Male Subjects Under Fasting and Fed ConditionsShashank Joshi, Girish Gudi, Vinu C A Menon, et al.
The Journal of the Association of Physicians of India|February 15, 2013
Diagnosis of gestational diabetes mellitus in the communityV Seshiah, V Balaji, Siddharth N Shah, et al.
The Journal of the Association of Physicians of India|July 21, 2019
Use of Ambulatory Glucose Profile for Improving Monitoring and Management of T2DMBanshi Saboo, Shruti V Sheth, Shashank Joshi, et al.
The Journal of the Association of Physicians of India|June 17, 2024
Evolution of Metabolic Syndrome in Newly Diagnosed Type 2 Diabetes Mellitus Asian-Indian Patients Over the Last 15 Years using Adult Treatment Panel III of the National Cholesterol Education Program, World Health Organization, and International Diabetes Federation CriterionHarshpreet Singh Tuteja, Nikhil Nassikar, Krish Panikar, et al.
Scientific Reports|October 27, 2024
One-year outcomes of a digital twin intervention for type 2 diabetes: a retrospective real-world studyParamesh Shamanna, Ravi Sankar Erukulapati, Ashutosh Shukla, et al.
International Journal of Clinical Pharmacology and Therapeutics|October 23, 2020
Effects of empagliflozin on proinflammatory cytokines and other coronary risk factors in patients with type 2 diabetes mellitus: A single-arm real-world observationRam B Singh, Ghizal Fatima, Puneet Kumar, et al.
Pageof 12

Showing results (61-70 of 113) with videos related to

Sort By:
Pageof 12
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|January 27, 2023
Expert Consensus Recommendations on Time in Range for Monitoring Glucose Levels in People with Diabetes: An Indian PerspectiveViswanathan Mohan, Shashank Joshi, Ambrish Mithal, et al.
The Lancet Regional Health. Southeast Asia|November 14, 2022
Correction to "SARS-CoV-2 accelerated clearance using a novel nitric oxide nasal spray (NONS) treatment: A randomized trial"Monika Tandon, Wen Wu, Keith Moore, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|March 25, 2022
Expert Opinion: Optimum Clinical Approach to Combination-Use of SGLT2i + DPP4i in the Indian Diabetes SettingManoj Chadha, Ashok Kumar Das, Prasun Deb, et al.
Clinical Diabetes and Endocrinology|November 15, 2021
Type 2 diabetes reversal with digital twin technology-enabled precision nutrition and staging of reversal: a retrospective cohort studyParamesh Shamanna, Shashank Joshi, Lisa Shah, et al.
Clinical Pharmacokinetics|October 5, 2019
An Open-Label, Single-Period, Two-Stage, Single Oral Dose Pharmacokinetic Study of Remogliflozin Etabonate Tablet 100 and 250 mg in Healthy Asian Indian Male Subjects Under Fasting and Fed ConditionsShashank Joshi, Girish Gudi, Vinu C A Menon, et al.
The Journal of the Association of Physicians of India|February 15, 2013
Diagnosis of gestational diabetes mellitus in the communityV Seshiah, V Balaji, Siddharth N Shah, et al.
The Journal of the Association of Physicians of India|July 21, 2019
Use of Ambulatory Glucose Profile for Improving Monitoring and Management of T2DMBanshi Saboo, Shruti V Sheth, Shashank Joshi, et al.
The Journal of the Association of Physicians of India|June 17, 2024
Evolution of Metabolic Syndrome in Newly Diagnosed Type 2 Diabetes Mellitus Asian-Indian Patients Over the Last 15 Years using Adult Treatment Panel III of the National Cholesterol Education Program, World Health Organization, and International Diabetes Federation CriterionHarshpreet Singh Tuteja, Nikhil Nassikar, Krish Panikar, et al.
Scientific Reports|October 27, 2024
One-year outcomes of a digital twin intervention for type 2 diabetes: a retrospective real-world studyParamesh Shamanna, Ravi Sankar Erukulapati, Ashutosh Shukla, et al.
International Journal of Clinical Pharmacology and Therapeutics|October 23, 2020
Effects of empagliflozin on proinflammatory cytokines and other coronary risk factors in patients with type 2 diabetes mellitus: A single-arm real-world observationRam B Singh, Ghizal Fatima, Puneet Kumar, et al.
Pageof 12